Alv B, in co-operation with the Veterinary School at the Norwegian Life Science University (NMBU) has cleared the regulatory requirements to accept patients that will be subjected to a novel approach of treating lung metastasis in cancer patients.
This is the very first of several clinical protocols in Alv B’s immunotherapeutic pipeline that has now reached clinical stage.
We are now recruiting privately owned dogs, who have developed lung metastases from a spontaneous cancer which has currently not responded to treatment or is untreatable.
If you are a veterinarian wanting to refer patients for treatment, please e-mikael.mathias.kerboeuf@nmbu.no.
